Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Anastasi
Observed names:
F Anastasi,
F. Anastasi
Institution:
Saint Camillus International University of Health and Medical Sciences
Observed institution:
Saint Camillus International University of Health and Medical Sciences
ORCID:
0000-0002-6566-6909
Observed ORCID:
0000-0002-6566-6909
OpenAlex ID:
A5046486698
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps ( CRSwNP ): A multicentric observational Phase IV real‐life study ( DUPIREAL )
2023
·
Eugenio De Corso
, Ernesto Pasquini
, et al.
·
Allergy
·
196
PDF
Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Allergy
·
29
Efficacy and limitations of systemic corticosteroids in patients with CRSwNP compared to alternative therapies with monoclonal antibodies: real-life of 101 patients from the Lazio region, Italy
2025
·
F. Anastasi
, C. Di Nota
, et al.
·
Frontiers in Allergy
·
7
PDF
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey
2025
·
Francesca Anastasi
, Frank Rikki Mauritz Canevari
, et al.
·
Frontiers in Allergy
·
5
PDF
A runny nose: an unexpected ferromagnetic foreign body in an unexpected place.
2004
·
F Rodolà
, F Anastasi
·
PubMed
·
4
Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial
2026
·
Eugenio De Corso
, Giancarlo Ottaviano
, et al.
·
The Lancet Respiratory Medicine
·
1
Living with chronic rhinosinusitis with nasal polyposis (CRSwNP): an experience to amplify Italian patients’ voices
2026
·
L. Bernardi
, M. R. Mollo
, et al.
·
Journal of Patient-Reported Outcomes
·
1
Show more works
View as search
Works count:
7
Citation count:
243
H-index:
4
I10-index:
2
Year
Topic
Type